Menu

Markets

Research

News

Learn
Paper trading
AI Chat
Get the app WatchlistsPortfoliosAlerts
Sign in

American Oncology Network, Inc. AONC

Full chart Compare
Set alert

Price alert · AONC

All alert types
11.50 USD 0.00 (+0.00%)

At closeFeb 5, 2026, 4:00 PM EST

10.50 Day range 11.12
0.001 52-week range 25.00
YTD
-4.17%
1 year
+27.78%

Financial health

Altman Z-Score

4.61 Safe zone

Bankruptcy-risk model: below 1.81 distress, above 2.99 safe.

Piotroski F-Score

3 / 9 Weak

Nine pass/fail tests of profitability, leverage and efficiency.

Valuation

P/E -7.3×
FY 2020: 13.0×FY 2021: -3900×FY 2022: 162×FY 2023: -4.3×FY 2024: -7.3×
FY 2020 5y median -4.3× FY 2024
P/S 0.0×
FY 2020: 0.4×FY 2021: 0.4×FY 2022: 0.4×FY 2023: 0.0×FY 2024: 0.0×
FY 2020 5y median 0.4× FY 2024
P/B 3.6×
FY 2020: 11862×FY 2021: 1.3×FY 2022: 6.8×FY 2023: -0.2×FY 2024: 3.6×
FY 2020 5y median 3.6× FY 2024
P/FCF -2.6×
FY 2020: 11.5×FY 2021: -11.7×FY 2022: -30.0×FY 2023: -1.3×FY 2024: -2.6×
FY 2020 5y median -2.6× FY 2024
EV/EBITDA 84.2×
FY 2020: 11.1×FY 2021: 56.4×FY 2022: 22.5×FY 2023: -3.5×FY 2024: 84.2×
FY 2020 5y median 22.5× FY 2024
EV/Sales 0.1×
FY 2020: 0.4×FY 2021: 0.5×FY 2022: 0.5×FY 2023: 0.1×FY 2024: 0.1×
FY 2020 5y median 0.4× FY 2024
FCF Yield -37.9%
FY 2020: 8.7%FY 2021: -8.5%FY 2022: -3.3%FY 2023: -77.1%FY 2024: -37.9%
FY 2020 5y median -8.5% FY 2024

Profitability

Gross Margin 6.7%
FY 2020: 9.1%FY 2021: 8.3%FY 2022: 8.3%FY 2023: 6.5%FY 2024: 6.7%
FY 2020 5y median 8.3% FY 2024
Operating Margin -1.0%
FY 2020: 3.0%FY 2021: 0.1%FY 2022: 0.5%FY 2023: -3.8%FY 2024: -1.0%
FY 2020 5y median 0.1% FY 2024
Net Margin -0.2%
FY 2020: 3.0%FY 2021: -0.0%FY 2022: 0.2%FY 2023: -0.4%FY 2024: -0.2%
FY 2020 5y median -0.0% FY 2024
ROE -21.2%
FY 2020: 90834.2%FY 2021: -0.0%FY 2022: 4.2%FY 2023: 3.4%FY 2024: -21.2%
FY 2020 5y median 3.4% FY 2024
ROIC -6.6%
FY 2020: 91334.9%FY 2021: -0.2%FY 2022: 2.9%FY 2023: -23.0%FY 2024: -6.6%
FY 2020 5y median -0.2% FY 2024
ROA -0.8%
FY 2020: 44766.0%FY 2021: -0.0%FY 2022: 0.8%FY 2023: -1.5%FY 2024: -0.8%
FY 2020 5y median -0.0% FY 2024

Growth (YoY)

Revenue 37.5%
FY 2020: 0.0%FY 2021: 30.2%FY 2022: 21.8%FY 2023: 11.3%FY 2024: 37.5%
FY 2020 FY 2024
Operating Income 64.5%
FY 2020: 0.0%FY 2021: -95.9%FY 2022: 511.0%FY 2023: -983.1%FY 2024: 64.5%
FY 2020 FY 2024
EPS (diluted) 49.3%
FY 2020: 0.0%FY 2021: -100.3%FY 2022: 2584.0%FY 2023: -2290.0%FY 2024: 49.3%
FY 2020 FY 2024
Free Cash Flow 14.8%
FY 2020: 0.0%FY 2021: -238.5%FY 2022: 59.7%FY 2023: -117.5%FY 2024: 14.8%
FY 2020 FY 2024

Financial Health

Current Ratio 1.5×
FY 2020: 1.0×FY 2021: 1.7×FY 2022: 1.7×FY 2023: 1.6×FY 2024: 1.5×
FY 2020 5y median 1.6× FY 2024
Quick Ratio 1.2×
FY 2020: 1.0×FY 2021: 1.5×FY 2022: 1.5×FY 2023: 1.4×FY 2024: 1.2×
FY 2020 5y median 1.4× FY 2024
Debt / Equity 7.9×
FY 2020: 0.0×FY 2021: 0.2×FY 2022: 2.0×FY 2023: -0.8×FY 2024: 7.9×
FY 2020 5y median 0.2× FY 2024
Net Debt / EBITDA 46.6×
FY 2020: -0.0×FY 2021: 4.6×FY 2022: 4.3×FY 2023: -2.5×FY 2024: 46.6×
FY 2020 5y median 4.3× FY 2024
Interest Coverage -2.5×
FY 2020: 19.8×FY 2021: 0.6×FY 2022: 1.6×FY 2023: -7.7×FY 2024: -2.5×
FY 2020 5y median 0.6× FY 2024

Dividends

Dividend Yield 0.0%
FY 2020: 0.0%FY 2021: 0.0%FY 2022: 0.0%FY 2023: 0.0%FY 2024: 0.0%
FY 2020 5y median 0.0% FY 2024
Payout Ratio 0.0%
FY 2020: 0.0%FY 2021: 0.0%FY 2022: 0.0%FY 2023: 0.0%FY 2024: 0.0%
FY 2020 5y median 0.0% FY 2024

Annual · latest fiscal year ends 2024-12-31